MNMD logo

Mind Medicine (MindMed) (MNMD) Company Overview

Profile

Full Name:

Mind Medicine (MindMed) Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 15, 2016

Indexes:

Not included

Website:

http://www.mindmed.co

Description:

Mind Medicine (MindMed) is a biotechnology company focused on developing psychedelic-inspired medicines to treat mental health disorders. They aim to create innovative therapies for conditions like anxiety, depression, and addiction, using research and clinical trials to explore the potential benefits of psychedelics in medicine.

Key Details

Price

$6.90

Market Cap

$505.99 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00

Annual EPS

-

PE Ratio

-

Annual ROE

-45.01%

Annual Debt To Equity

0.09

Beta

1.58

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 6, 2025

Recent annual earnings:

Mar 6, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 29, 2022

Analyst ratings

Recent major analysts updates

Jan 4, 22 HC Wainwright & Co.
Buy

Screeners with MNMD included

Growing Shares Outstanding
US stocks
Stocks with high beta
Stocks below SMA 200
Most recommended stocks
Best performing stocks last 5 years
Stocks below analysts price target
Healthcare sector
All stocks
NASDAQ Listed Companies

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$6.90
MNMD price is $6.90

Price All-time High

$70.35
MNMD price is currently -90.19% below its historical high of $70.35

Price Analysts Target

$20.00
MNMD price is currently -65.50% lower than the consensus analysts' forecast

Price Most Recent Change

+4.55%
MNMD price was up +4.55% on Mar 8, 2025

Price YTD Change

+2.22%
MNMD price is up +2.22% since January 1st

Price 3-Year Change

-54%
MNMD price is down -54% over the past 3 years

Market cap

Market Cap

$505.99 M
MNMD market capitalization is $505.99 million

Market Cap 3-Year Change

+20.06%
MNMD market capitalization is up +20.06% over the past 3 years

Market Cap All-time High

$1.59 B
MNMD market capitalization is currently -68.23% below its historical high of $1.59 billion

Market Cap Sector Rank

67.82%
MNMD market capitalization is higher than 67.82% of companies in Healthcare sector

Technical

Beta

1.58
MNMD beta is 1.58

200-day SMA

$7.15
MNMD price is currently -3.56% below its 200-day simple moving average

14-day RSI

45.28
MNMD 14-day relative strength index is 45.28

30-day Relative Volume

0.52
MNMD 30-day relative volume is 0.52

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$0.00
MNMD annual revenue is $0.00

Annual Revenue Analysts Estimate

-
MNMD annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
MNMD annual revenue 1-year change is unknown

Annual Revenue Sector Rank

5.21%
MNMD annual revenue is higher than 5.21% of companies in Healthcare sector

Profit

Annual Gross Profit

-
MNMD annual gross profit value is unknown

Annual Gross Margin

-
MNMD annual gross profit margin value is unknown

Annual Operating Profit

-$103.92 M
MNMD annual operating income is -$103.92 million

Annual Operating Margin

-
MNMD annual operating profit margin value is unknown

Annual Net Income

-$108.68 M
MNMD annual net profit is -$108.68 million

Annual Net Margin

-
MNMD annual net profit margin value is unknown

EPS

Annual EPS

-
MNMD annual earnings per share value is unknown

Annual EPS Analysts Estimate

-$1.61
MNMD annual earnings per share is currently equal to the consensus analysts' forecast

Annual EPS 1-Year Change

-
MNMD annual earnings per share 1-year change is unknown

Annual EPS Sector Rank

-
MNMD annual earnings per share is unknown

ROA & ROE

Annual ROA

-35.97%
MNMD annual return on assets is -35.97%

Annual ROE

-45.01%
MNMD annual return on equity is -45.01%

EBIT & EBITDA

Annual EBIT

-$106.40 M
MNMD annual earnings before interest & taxes is -$106.40 million

Annual EBITDA

-$91.83 M
MNMD annual EBITDA is -$91.83 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
MNMD price to earnings ratio value is unknown

PE Ratio Sector Rank

-
MNMD price to earnings ratio is unknown

PB Ratio

PB Ratio

2.10
MNMD price to book ratio is 2.10

PB Ratio Sector Rank

60.79%
MNMD price to book ratio is higher than 60.79% of companies in Healthcare sector

PS Ratio

PS Ratio

-
MNMD price to sales ratio value is unknown

PS Ratio Sector Rank

-
MNMD price to sales ratio is unknown

Enterprise value

Enterprise Value

$254.10 M
MNMD enterprise value is $254.10 million

Enterprise Value Sector Rank

59.67%
MNMD enterprise value is higher than 59.67% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.40
MNMD EV/EBITDA is -2.40

EV/EBITDA Sector Rank

33.1%
MNMD EV/EBITDA is higher than 33.1% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

7.25
MNMD annual current ratio is 7.25

Annual Quick Ratio

-
MNMD annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.09
MNMD annual debt to equity ratio is 0.09

Annual Interest Coverage Ratio

-46.60
MNMD annual interest coverage ratio is -46.60

Risk & Stability

Piotroski F-Score

-
MNMD piotroski f-score value is unknown

Altman Z-Score

2.96
MNMD altman z-score is 2.96

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$302.15 M
MNMD annual total assets is $302.15 million

Annual Non Current Assets

$20.53 M
MNMD annual long term assets is $20.53 million

Annual Current Assets

$281.62 M
MNMD annual total current assets is $281.62 million

Annual Cash & Cash Equivalents

$273.74 M
MNMD annual cash & cash equivalents is $273.74 million

Equity

Annual Book Value

$221.53 M
MNMD annual book value is $221.53 million

Annual Working Capital

$242.77 M
MNMD annual working capital is $242.77 million

Liabilities

Annual Total Liabilities

$60.70 M
MNMD annual total liabilities is $60.70 million

Annual Total Long Term Liabilities

$21.85 M
MNMD annual total long term liabilities is $21.85 million

Annual Current Liabilities

$38.85 M
MNMD annual total current liabilities is $38.85 million

Annual Accounts Payable

$2.01 M
MNMD annual accounts payable is $2.01 million

Debt

Annual Total Debt

$21.85 M
MNMD annual total debt is $21.85 million

Annual Total Debt 1-Year Change

+54.67%
MNMD annual total debt is up +54.67% year-on-year

Annual Long Term Debt

$21.85 M
MNMD annual long term debt is $21.85 million

Annual Short Term Debt

-
MNMD annual short term debt value is unknown

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$103.92 M
MNMD annual total expenses is $103.92 million

Annual Operating Expenses

$103.92 M
MNMD annual total operating expenses is $103.92 million

Annual Cost Of Goods Sold

-
MNMD annual cost of goods sold value is unknown

Annual SGA

$38.62 M
MNMD annual SGA is $38.62 million

Annual D&A

$527.00 K
MNMD annual depreciation & amortization is $527.00 thousand

Annual Interest Expense

$2.28 M
MNMD annual interest expense is $2.28 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$79.13 M
MNMD annual cash flow from operations is -$79.13 million

Annual CFO 1-Year Change

-22.94%
MNMD annual cash flow from operations is down -22.94% year-on-year

Annual CFI

-
MNMD annual cash flow from investing activities value is unknown

Annual CFI 1-Year Change

-
MNMD annual cash flow from investing activities 1-year change is unknown

Annual CFF

$253.20 M
MNMD annual cash flow from financing activities is $253.20 million

Annual CFF 1-Year Change

+1058.9%
MNMD annual cash flow from financing activities is up +1058.9% year-on-year

Free CashFlow

Annual FCF

-$79.13 M
MNMD annual free cash flow is -$79.13 million

Annual FCF 1-Year Change

-22.94%
MNMD annual free cash flow is down -22.94% year-on-year

CAPEX

Annual CAPEX

-
MNMD annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
MNMD annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

CGEM logo
Cullinan Oncology (CGEM)
ANAB logo
AnaptysBio (ANAB)
EYPT logo
EyePoint Pharmaceuticals (EYPT)
TALK logo
Talkspace (TALK)
Maze Therapeutics (MAZE)
ABVX logo
ABIVAX SA (ABVX)
VREX logo
Varex Imaging (VREX)
CCRN logo
Cross Country Healthcare (CCRN)
MGTX logo
MeiraGTx Holdings (MGTX)

FAQ

  • What is the ticker symbol for Mind Medicine (MindMed)?
  • Does Mind Medicine (MindMed) pay dividends?
  • What sector is Mind Medicine (MindMed) in?
  • What industry is Mind Medicine (MindMed) in?
  • What country is Mind Medicine (MindMed) based in?
  • When did Mind Medicine (MindMed) go public?
  • Is Mind Medicine (MindMed) in the S&P 500?
  • Is Mind Medicine (MindMed) in the NASDAQ 100?
  • Is Mind Medicine (MindMed) in the Dow Jones?
  • When was Mind Medicine (MindMed)'s last earnings report?
  • When does Mind Medicine (MindMed) report earnings?
  • Should I buy Mind Medicine (MindMed) stock now?

What is the ticker symbol for Mind Medicine (MindMed)?

The ticker symbol for Mind Medicine (MindMed) is NASDAQ:MNMD

Does Mind Medicine (MindMed) pay dividends?

No, Mind Medicine (MindMed) does not pay dividends

What sector is Mind Medicine (MindMed) in?

Mind Medicine (MindMed) is in the Healthcare sector

What industry is Mind Medicine (MindMed) in?

Mind Medicine (MindMed) is in the Biotechnology industry

What country is Mind Medicine (MindMed) based in?

Mind Medicine (MindMed) is headquartered in United States

When did Mind Medicine (MindMed) go public?

Mind Medicine (MindMed)'s initial public offering (IPO) was on November 15, 2016

Is Mind Medicine (MindMed) in the S&P 500?

No, Mind Medicine (MindMed) is not included in the S&P 500 index

Is Mind Medicine (MindMed) in the NASDAQ 100?

No, Mind Medicine (MindMed) is not included in the NASDAQ 100 index

Is Mind Medicine (MindMed) in the Dow Jones?

No, Mind Medicine (MindMed) is not included in the Dow Jones index

When was Mind Medicine (MindMed)'s last earnings report?

Mind Medicine (MindMed)'s most recent earnings report was on Mar 6, 2025

When does Mind Medicine (MindMed) report earnings?

The date for Mind Medicine (MindMed)'s next earnings report has not been announced yet

Should I buy Mind Medicine (MindMed) stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions